Gilead Sciences, Inc.

NASDAQ:GILD   3:59:59 PM EDT
67.47
+0.25 (+0.37%)
4:00:00 PM EDT: $67.47 0.00 (0.00%)
Mergers / Acquisitions

HBM Healthcare Investments: Gilead Sciences To Acquire HBM Portfolio Company Immunomedics

Published: 09/14/2020 05:34 GMT
Gilead Sciences, Inc. (GILD) - Gilead Sciences to Acquire Hbm Portfolio Company Immunomedics.
Gilead Will Acquire Immunomedics for USD 88.00 per Share in Cash.
Anticipated to Close During Q4 of 2020.